Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where João Costa-Rodrigues is active.

Publication


Featured researches published by João Costa-Rodrigues.


Marine Drugs | 2012

Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis

Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins

Marine cyanobacteria have been considered a rich source of secondary metabolites with potential biotechnological applications, namely in the pharmacological field. Chemically diverse compounds were found to induce cytoxicity, anti-inflammatory and antibacterial activities. The potential of marine cyanobacteria as anticancer agents has however been the most explored and, besides cytotoxicity in tumor cell lines, several compounds have emerged as templates for the development of new anticancer drugs. The mechanisms implicated in the cytotoxicity of marine cyanobacteria compounds in tumor cell lines are still largely overlooked but several studies point to an implication in apoptosis. This association has been related to several apoptotic indicators such as cell cycle arrest, mitochondrial dysfunctions and oxidative damage, alterations in caspase cascade, alterations in specific proteins levels and alterations in the membrane sodium dynamics. In the present paper a compilation of the described marine cyanobacterial compounds with potential anticancer properties is presented and a review on the implication of apoptosis as the mechanism of cell death is discussed.


Acta Biomaterialia | 2012

Hydroxyapatite surface roughness: Complex modulation of the osteoclastogenesis of human precursor cells

João Costa-Rodrigues; A. Fernandes; Maria A. Lopes; Maria Helena Fernandes

It is recognized that the surface roughness affects osteoblastic differentiation, but little information is available regarding its effect on osteoclastogenesis. With this work, the osteoclastogenic behaviour of human peripheral blood mononuclear cells (PBMCs), cultured isolated (1.5×10(6)cellscm(-2)) or co-cultured with human bone marrow cells (hBMCs; 10(3)cellscm(-2)), was assessed on surface-abraded hydroxyapatite disks with three different surface roughnesses (R(a) 0.0437-0.582 μm). Monocultures and co-cultures were performed for 21 days in the absence or presence of recombinant M-CSF and RANKL. Results showed that PBMCs supplemented with M-CSF and RANKL or co-cultured with hBMCs displayed typical osteoclastic features, i.e. multinucleated cells with actin rings, vitronectin and calcitonin receptors, gene expression of TRAP, cathepsin K, carbonic anhydrase 2, c-myc and c-src, TRAP activity and resorbing activity. The osteoclastogenic response increased with surface roughness in PBMCs cultured with M-CSF and RANKL but decreased in PBMCs co-cultured with hBMCs. However, co-cultures supplemented with the osteoclastogenic inducers displayed high and similar levels of osteoclast differentiation in the three tested surfaces. In conclusion, modulation of osteoclast differentiation by surface roughness seemed to be dependent on the mechanisms subjacent to the osteoclastogenic stimulus, i.e. the presence of soluble factors or direct cell-to-cell contacts between osteoblastic and osteoclastic cells.


FEBS Journal | 2013

Dose‐dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity

João Costa-Rodrigues; Sara Reis; Sónia Teixeira; Sandra Lopes; Maria Helena Fernandes

Proton pump inhibitors (PPIs), a class of molecules that are used to decrease gastric acid production, might have adverse effects on bone metabolism. The aim of this study was to characterize the concentration‐dependent and time‐dependent effects of three PPIs (omeprazole, esomeprazole, and lansoprazole) on human osteoclast precursor cells isolated from peripheral blood, and on human mesenchymal stem cells (osteoblast precursors). Cell cultures were characterized for total protein content, apoptosis, and several osteoclastic/osteoblastic features, and also for the involvement of some intracellular signaling pathways. PPIs caused a dose‐dependent decrease in cellular density, which correlated with an increase in the apoptosis rate, effects that became statistically significant at concentrations ≥ 10−5 m. They also inhibited phenotype‐related gene expression and functional parameters. For both cell types, cellular function, i.e. osteoclastic resorption and the formation of mineralized deposits by osteoblastic cells, was more affected than proliferation‐related parameters. The three PPIs showed similar qualitative and quantitative effects, but displayed some differences in the underlying intracellular signaling pathways. These results suggest that PPIs might have a direct deleterious effect on bone cells, with the possibility of decreased bone turnover.


Cell Proliferation | 2011

Spontaneous and induced osteoclastogenic behaviour of human peripheral blood mononuclear cells and their CD14 + and CD14 ) cell fractions

João Costa-Rodrigues; A. Fernandes; M.H. Fernandes

Objectives:  Osteoclasts are descended from the CD14+ monocyte/macrophage lineage, but influence of other haematopoietic cells on osteoclastic commitment of their precursors has remained poorly understood. In this study, osteoclastogenic behaviour of peripheral blood mononuclear cells (PBMC) and their CD14+ and CD14− subpopulations has been accessed, in the absence or presence of M‐CSF and RANKL.


Cell Biochemistry and Biophysics | 2004

Protein translocation across the peroxisomal membrane.

Jorge E. Azevedo; João Costa-Rodrigues; Carla P. Guimarães; Márcia E. Oliveira; Clara Sá-Miranda

Peroxisomal matrix proteins are synthesized on free cytosolic ribosomes and posttranslationally imported into the organelle. Translocation of these newly synthesized proteins across the peroxisomal membrane requires the concerted action of many different proteins, the majority of which were already identified. However, not much is known regarding the mechanism, of protein translocation across this membrane system. Here, we discuss recent mechanistic and structural data. These results point to a model in which proteins en route to the peroxisomal matrix are translocated across the organelle membrane by their own receptor in a process that occurs, through a large membrane protein assembly.


Marine Drugs | 2013

Exploring Bioactive Properties of Marine Cyanobacteria Isolated from the Portuguese Coast: High Potential as a Source of Anticancer Compounds

Margarida Costa; Mónica P. Garcia; João Costa-Rodrigues; Maria Sofia Costa; Maria João Ribeiro; Maria Helena Fernandes; Piedade Barros; Aldo Barreiro; Vitor Vasconcelos; Rosário Martins

The oceans remain a major source of natural compounds with potential in pharmacology. In particular, during the last few decades, marine cyanobacteria have been in focus as producers of interesting bioactive compounds, especially for the treatment of cancer. In this study, the anticancer potential of extracts from twenty eight marine cyanobacteria strains, belonging to the underexplored picoplanktonic genera, Cyanobium, Synechocystis and Synechococcus, and the filamentous genera, Nodosilinea, Leptolyngbya, Pseudanabaena and Romeria, were assessed in eight human tumor cell lines. First, a crude extract was obtained by dichloromethane:methanol extraction, and from it, three fractions were separated in a Si column chromatography. The crude extract and fractions were tested in eight human cancer cell lines for cell viability/toxicity, accessed with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and lactic dehydrogenase release (LDH) assays. Eight point nine percent of the strains revealed strong cytotoxicity; 17.8% showed moderate cytotoxicity, and 14.3% assays showed low toxicity. The results obtained revealed that the studied genera of marine cyanobacteria are a promising source of novel compounds with potential anticancer activity and highlight the interest in also exploring the smaller filamentous and picoplanktonic genera of cyanobacteria.


Journal of Cellular Biochemistry | 2009

Characterisation of the Osteoclastogenic Potential of Human Osteoblastic and Fibroblastic Conditioned Media

João Costa-Rodrigues; Cristina Teixeira; Paula Sampaio; Maria Helena Fernandes

Although M‐CSF and RANKL are sufficient to promote in vitro osteoclastogenesis, in vivo this is a complex process which requires the action of many signalling molecules and cellular crosstalks. In this work, isolated or combined conditioned media, obtained from human adult skin fibroblast and bone marrow cells, were tested for their osteoclastogenic potential, through an indirect co‐culture system, in the absence of recombinant M‐CSF and RANKL. Osteoclastogenesis was assessed on human peripheral blood mononuclear cells (PBMC) and CD14+ cell cultures by quantification of total protein content, tartrate‐resistant acid phosphatase (TRAP) activity, presence of multinucleated cells positive for TRAP, RT‐PCR of TRAP, CATK, CA2, c‐myc and c‐src and presence of multinucleated cells displaying actin rings, vitronectin and calcitonin receptors. Cultures supplemented with M‐CSF and RANKL were used as positive controls. It was observed that the conditioned medium from dexamethasone osteogenic‐induced bone marrow cell cultures displayed the highest osteoclastogenic potential, with similar behaviour to that observed in the presence of both M‐CSF and RANKL. Comparatively, fibroblastic conditioned medium elicited a slightly lower osteoclastogenic response. Combination of both conditioned media resulted in a significant increase of TRAP activity. On the other hand, conditioned medium from non‐osteogenic‐induced bone marrow cell cultures presented the lowest osteoclastogenic potential. These results were observed for both PBMC and CD14+ cell cultures, suggesting that fibroblast and osteoblast cells are able to modulate osteoclastogenesis in the absence of physical cell–cell interactions. In addition, osteoclastogenic potential of bone marrow cells increases with their osteoblastic differentiation. J. Cell. Biochem. 109: 205–216, 2010.


Journal of Cellular Biochemistry | 2011

Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors

João Costa-Rodrigues; A. Fernandes; Maria Helena Fernandes

Osteosarcoma is usually associated with a disturbed bone metabolism. The aim of this work was to characterize the reciprocal interactions between MG63 osteosarcoma cells and osteoclasts, in a co‐culture system. Co‐cultures were characterized throughout 21 days for the osteoclastogenic response and the expression of osteoblastic markers. Monocultures of MG63 cells and peripheral blood mononuclear cell (PBMC) and co‐cultures of PBMC + human bone marrow cells (hBMC) were also performed. Compared to PBMC cultures, co‐cultures yielded significantly increased gene expression of osteoclast‐related markers, tartarate‐acid resistant phosphatase (TRAP) activity, TRAP‐positive multinucleated cells, cells with actin rings and vitronectin receptors (VNR) and calcitonin receptors (CTR) and calcium phosphate resorbing ability. Results showed that the development of functional osteoclasts required a very low number of MG63 cells, suggesting a high osteoclastogenic‐triggering capacity of this cell line. Subjacent mechanisms involved the pathways MEK and NF‐kB, although with a lower relevance than that observed on PBMC monocultures or co‐cultures of hBMC + PBMC; PGE2 production also had a contribution. Compared to MG63 cell monocultures, the co‐culture expressed lower levels of COL1 and ALP, and higher levels of BMP‐2, suggesting that PBMC also modulated the osteoblastic behavior. While M‐CSF appeared to be involved in the osteoclastogenic response on the MG63 + PBMC co‐cultures, RANKL does not seem to be a key player in the process. On the other hand, sphingosine‐1‐phosphate production might contribute to the modulation of the osteoblastic behavior. Results suggest that the reciprocal modulation between osteosarcoma and osteoclastic cells might contribute to the disturbed bone metabolism associated with bone tumors. J. Cell. Biochem. 112: 3704–3713, 2011.


Cell Proliferation | 2011

Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts

João Costa-Rodrigues; M.H. Fernandes

Objective:  Fibroblasts appear to modulate osteoclastogenesis, but their precise role in this process remains unclear. In this work, paracrine‐mediated osteoclastogenic potential of different human fibroblasts was assessed.


Cell Proliferation | 2012

Equisetum arvense hydromethanolic extracts in bone tissue regeneration: in vitro osteoblastic modulation and antibacterial activity.

C. Bessa Pereira; Pedro Gomes; João Costa-Rodrigues; R. Almeida Palmas; Luís Vieira; M.P. Ferraz; Maria A. Lopes; M.H. Fernandes

E quisetum arvense preparations have long been used to promote bone healing. The aim of this work was to evaluate osteogenic and antibacterial effects of E . arvense hydromethanolic extracts.

Collaboration


Dive into the João Costa-Rodrigues's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Clara Sá-Miranda

Instituto de Biologia Molecular e Celular

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marc Fransen

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.P. Noronha

Universidade Nova de Lisboa

View shared research outputs
Top Co-Authors

Avatar

Ricardo Ferraz

Instituto Politécnico Nacional

View shared research outputs
Researchain Logo
Decentralizing Knowledge